CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Other Non Operating Income came in at -$42.0 million in Q3 2021, down 110.0% YoY from $420.0 million in Q3 2020, and down 107592.31% on a QoQ basis from -$39000.0 in Q2 2021.
CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Other Non Operating Income data on file, last reported at -$42.0 million in Q3 2021.
- Quarterly Other Non Operating Income fell 110.0% year-over-year to -$42.0 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was -$49.8 million (down 155.85% YoY) and the FY2020 annual result came in at $181000.0, down 21.3% from the prior year.
- Other Non Operating Income slipped to -$42.0 million in Q3 2021, from -$39000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $511000.0 in Q4 2019 to a low of -$42.0 million in Q3 2021.
- A 4-year average of -$4.6 million and a median of -$65000.0 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2019 — Other Non Operating Income jumped 755.13% — and 2020, when it tumbled 51182.05%.
- Tracing CLGN's Other Non Operating Income over 4 years: stood at -$78000.0 in 2018, then jumped by 755.13% to $511000.0 in 2019, then slumped by 1630.14% to -$7.8 million in 2020, then plunged by 437.15% to -$42.0 million in 2021.
- The last three Other Non Operating Income figures came in at -$42.0 million (Q3 2021), -$39000.0 (Q2 2021), and $67000.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -42.00 Mn |
| Jun 30, 2021 | -39,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Dec 31, 2020 | -7.82 Mn |
| Sep 30, 2020 | -20.00 Mn |
| Jun 30, 2020 | -65,000.00 |
| Mar 31, 2020 | 93,000.00 |
| Dec 31, 2019 | 511,000.00 |
| Sep 30, 2019 | -39,000.00 |
| Jun 30, 2019 | -111,000.00 |
| Mar 31, 2019 | -131,000.00 |
| Dec 31, 2018 | -78,000.00 |
| Sep 30, 2018 | -109,000.00 |
| Jun 30, 2018 | -40,000.00 |
| Mar 31, 2018 | 143,000.00 |